Temat: "Costs" - OpacWWW - Prolib Integro

Skocz do pozycji: 1 1.

Tytuł :: German Pharmaceutical Pricing: Lessons for the United States.
Autorzy :: Rodwin MA; 1850Suffolk University, Boston, MA, USA.
Gerke S; Penn State Dickinson Law, Carlisle, PA, USA.; Pokaż więcej
Źródło :: International journal of health services : planning, administration, evaluation [Int J Health Serv] 2022 Jan; Vol. 52 (1), pp. 146-158. Date of Electronic Publication: 2021 Oct 20.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Costs*
Pharmaceutical Preparations*
Costs and Cost Analysis ; Germany ; Humans ; National Health Programs ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan.
Autorzy :: Maeda H; Department of Regulatory Science, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan. .
Okabe A; Department of Regulatory Science, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan.
Sakakura K; Department of Public Health and Epidemiology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, Japan.; Daiichi Sankyo Co., Ltd., 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, 103-8426, Japan.
Ng DB; Department of Health Economy Outcome Research, Astellas Pharma Global Development, Singapore, Singapore.; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois, USA.
Akazawa M; Department of Public Health and Epidemiology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, Japan.; Pokaż więcej
Źródło :: BMC health services research [BMC Health Serv Res] 2021 Dec 11; Vol. 21 (1), pp. 1329. Date of Electronic Publication: 2021 Dec 11.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents*
Drug Costs*
Costs and Cost Analysis ; Humans ; Japan
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Testing and Treating Helicobacter pylori Infection in Individuals With Family History of Gastric Cancer is Cost-effective.
Autorzy :: Rustgi SD; Department of Medicine, Vagelos College of Physician and Surgeons, Columbia University, New York, New York; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
Oh A; Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.
Hur C; Department of Medicine, Vagelos College of Physician and Surgeons, Columbia University, New York, New York; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York; Healthcare Innovations Research and Evaluation, Department of Medicine, Columbia University Irving Medical Center, New York, New York. Electronic address: .; Pokaż więcej
Źródło :: Gastroenterology [Gastroenterology] 2021 Dec; Vol. 161 (6), pp. 2051-2052.e4. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji :: Comparative Study; Letter; Research Support, N.I.H., Extramural
MeSH Terms :: Health Care Costs*
Diagnostic Screening Programs/*economics
Helicobacter Infections/*diagnosis
Helicobacter Infections/*drug therapy
Helicobacter Infections/*economics
Helicobacter pylori/*drug effects
Stomach Neoplasms/*economics
Stomach Neoplasms/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Breath Tests/economics ; Cost Savings ; Cost-Benefit Analysis ; Drug Costs ; Female ; Genetic Predisposition to Disease ; Health Status ; Helicobacter Infections/microbiology ; Helicobacter pylori/pathogenicity ; Heredity ; Humans ; Immunologic Tests/economics ; Male ; Markov Chains ; Middle Aged ; Models, Economic ; Pedigree ; Predictive Value of Tests ; Quality of Life ; Quality-Adjusted Life Years ; Risk Assessment ; Risk Factors ; Stomach Neoplasms/genetics ; Stomach Neoplasms/microbiology ; Time Factors ; Treatment Outcome
: Raport

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Product patents and access to innovative medicines.
Autorzy :: Dai R; The Graduate Institute of International and Development Studies (IHEID), Maison de la Paix, Chemin Eugène-Rigot 2A, 1202, Geneva, Switzerland. Electronic address: .
Watal J; Georgetown Law School, Georgetown University, 600 New Jersey Ave NW, Washington DC, 20001, United States. Electronic address: .; Pokaż więcej
Źródło :: Social science & medicine (1982) [Soc Sci Med] 2021 Dec; Vol. 291, pp. 114479. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Costs*
Drugs, Generic*/economics
Costs and Cost Analysis ; Developing Countries ; Health Services Accessibility ; Income ; Patents as Topic ; Poverty
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: A comparison of medication access services at 340B and non-340B hospitals.
Autorzy :: Rana I; Department of Pharmacy, Houston Methodist, 7550 Greenbriar Dr., Houston, TX, 77030, USA. Electronic address: .
von Oehsen W; Powers Pyles Sutter & Verville PC, 1501 M Street NW, Seventh Floor, Washington, D.C, 20005, USA. Electronic address: .
Nabulsi NA; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA. Electronic address: .
Sharp LK; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA. Electronic address: .
Donnelly AJ; Department of Pharmacy Practice, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA; Department of Pharmacy, UI Health, 1740 W. Taylor St., Chicago IL, 60612, USA. Electronic address: .
Shah SD; Howard Brown Health, 1025 W. Sunnyside Ave., Chicago, IL, 66040, USA. Electronic address: .
Stubbings J; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA; Department of Pharmacy Practice, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA. Electronic address: .
Durley SF; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA; Department of Pharmacy Practice, University of Illinois Chicago, College of Pharmacy, 833 S. Wood St., Chicago, IL, 60612, USA; Department of Pharmacy, UI Health, 1740 W. Taylor St., Chicago IL, 60612, USA. Electronic address: .; Pokaż więcej
Źródło :: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2021 Nov; Vol. 17 (11), pp. 1887-1892. Date of Electronic Publication: 2021 Mar 20.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Drug Costs*
Medicare*
Aged ; Costs and Cost Analysis ; Health Services Accessibility ; Hospitals ; Humans ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Global access to affordable direct oral anticoagulants.
Autorzy :: Neumann I; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Schünemann HJ; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
Bero L; Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Aurora, United States of America.
Cooke G; Department of Infectious Diseases, Imperial College London, London, England.
Magrini N; Italian Medicines Agency, Rome, Italy.
Moja L; Secretariat of the Model List of Essential Medicines, Department of Essential Health Products and Standards, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.; Pokaż więcej
Źródło :: Bulletin of the World Health Organization [Bull World Health Organ] 2021 Sep 01; Vol. 99 (9), pp. 653-660. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Costs*
Anticoagulants/*economics
Drugs, Essential/*supply & distribution
Drugs, Generic/*supply & distribution
Health Services Accessibility/*statistics & numerical data
Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; Costs and Cost Analysis ; Drugs, Essential/economics ; Drugs, Generic/economics ; Health Care Costs ; Humans
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study.
Autorzy :: Custodio A; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, CIBERONC CB16/12/00398, Madrid, Spain. .
Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Carmona-Bayonas A; Haematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, CP13/00126, PI17/0050 (ISCII & FEDER), Murcia, Spain.; Fundación Séneca (04515/GERM/06), Murcia, Spain.
Gomez MJ; Medical Oncology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Del Olmo-García MI; Medical Oncology Department, Hospital La Fe, Valencia, Spain.
Lorenzo I; Endocrinology Service, Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain.
Díaz JÁ; Endocrinology Service, Hospital Clínico de San Carlos, Madrid, Spain.
Canal N; IQVIA, Barcelona, Spain.
De la Cruz G; Ipsen, Hospitalet de Llobregat, Barcelona, Spain.
Villabona C; Endocrinology Service, Hospital Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.; Pokaż więcej
Źródło :: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Oct; Vol. 23 (10), pp. 2046-2056. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study
MeSH Terms :: Health Care Costs*/statistics & numerical data
Health Services Needs and Demand/*economics
Malignant Carcinoid Syndrome/*economics
Absenteeism ; Adult ; Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Direct Service Costs ; Emergency Service, Hospital/statistics & numerical data ; Female ; Health Services Needs and Demand/statistics & numerical data ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Hospitals, University/statistics & numerical data ; Humans ; Male ; Malignant Carcinoid Syndrome/pathology ; Malignant Carcinoid Syndrome/therapy ; Middle Aged ; Neuroendocrine Tumors/economics ; Neuroendocrine Tumors/pathology ; Neuroendocrine Tumors/therapy ; Presenteeism/statistics & numerical data ; Retrospective Studies ; Spain ; Work/statistics & numerical data
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: A comparison between the effects of drug costs and share of family income on drug costs in determining drug price.
Autorzy :: Dong X; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Room 214, Memphis, TN.
Tsang CCS; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Room 212, Memphis, TN.
Kotian A; College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN.
Zeng J; College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN.
Tran M; College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN.
Wang J; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Room 221, Memphis, TN.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Aug 06; Vol. 100 (31), pp. e26877.
Typ publikacji :: Journal Article
MeSH Terms :: Cost of Illness*
Costs and Cost Analysis*
Health Expenditures*
Health Services Accessibility*/standards
Health Services Accessibility*/statistics & numerical data
Income/*statistics & numerical data
Prescription Drugs/*economics
Drug Costs/standards ; Drug Costs/statistics & numerical data ; Family Characteristics ; Female ; Financial Stress ; Health Services Needs and Demand ; Humans ; Male ; Middle Aged ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Variables affecting pricing of orphan drugs: the Italian case.
Autorzy :: Jommi C; Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy. .
Listorti E; Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy.
Villa F; Aifa (Italian Medicines Agency), Via del Tritone 181, 00187, Rome, Italy.; Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Guido Donegani, 2, 28100, Novara, Italy.
Ghislandi S; Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy.; Department of Social and Political Sciences, Bocconi University, Via Rontgen 1, 20136, Milan, Italy.
Genazzani A; Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Guido Donegani, 2, 28100, Novara, Italy.
Cangini A; Aifa (Italian Medicines Agency), Via del Tritone 181, 00187, Rome, Italy.
Trotta F; Aifa (Italian Medicines Agency), Via del Tritone 181, 00187, Rome, Italy.; Pokaż więcej
Źródło :: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2021 Oct 19; Vol. 16 (1), pp. 439. Date of Electronic Publication: 2021 Oct 19.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Costs*
Orphan Drug Production*
Budgets ; Health Care Costs ; Humans ; Italy ; Rare Diseases/drug therapy
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 10 10.

Tytuł :: The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Autorzy :: Frank RG; Harvard University, Boston, MA, USA.; National Bureau of Economic Research, Cambridge, MA, USA.
Hicks A; Harvard University, Boston, MA, USA.
Berndt ER; National Bureau of Economic Research, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, MA, USA.; Pokaż więcej
Źródło :: Medical care research and review : MCRR [Med Care Res Rev] 2021 Oct; Vol. 78 (5), pp. 585-590. Date of Electronic Publication: 2020 May 29.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Costs*
Drugs, Generic*/economics
Pharmacies*
Costs and Cost Analysis ; Prescription Drugs/economics ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members.
Autorzy :: Trish E; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.; Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles.
Gascue L; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
Ribero R; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
Van Nuys K; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.; Department of Health Policy and Management, Price School of Public Policy, University of Southern California, Los Angeles.
Joyce G; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.; Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles.; Pokaż więcej
Źródło :: JAMA internal medicine [JAMA Intern Med] 2021 Oct 01; Vol. 181 (10), pp. 1414-1416.
Typ publikacji :: Journal Article
MeSH Terms :: Costs and Cost Analysis*
Drugs, Generic*/economics
Drugs, Generic*/therapeutic use
Fees, Pharmaceutical*
Prescription Drugs*/economics
Prescription Drugs*/therapeutic use
Community-Based Health Insurance/economics ; Drug Costs ; Humans ; Insurance, Pharmaceutical Services/economics ; Medicare Part D/economics ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database.
Autorzy :: Rees P; Population Policy and Practice, University College London Institute of Child Health, London, UK .
Carter B; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Gale C; Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Petrou S; Nuffield Department of Primary Care and Health Science, University of Oxford, Oxford, UK.
Botting B; Population Policy and Practice, University College London Institute of Child Health, London, UK.
Sutcliffe AG; Population Policy and Practice, University College London Institute of Child Health, London, UK.; Pokaż więcej
Źródło :: Archives of disease in childhood. Fetal and neonatal edition [Arch Dis Child Fetal Neonatal Ed] 2021 Sep; Vol. 106 (5), pp. 494-500. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Hospital Costs*
Neonatal Abstinence Syndrome/*economics
State Medicine/*economics
Databases, Factual ; Direct Service Costs ; England/epidemiology ; Humans ; Incidence ; Infant, Newborn ; Length of Stay/economics ; Neonatal Abstinence Syndrome/drug therapy ; Neonatal Abstinence Syndrome/epidemiology ; Nurseries, Hospital/economics ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Government Pharmaceutical Development to Address High Prices: Challenges Ahead.
Autorzy :: Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St., Suite 3030, Boston, MA, 02120, USA. .; Department of Law and Taxation, Bentley University, Waltham, MA, 02452, USA. .; Pokaż więcej
Źródło :: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2021 Sep; Vol. 55 (5), pp. 1103-1105. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Costs*
Drug Industry*
Costs and Cost Analysis ; Drug Development ; Government ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: A reply to "Who would benefit from average value-based pricing?"
Autorzy :: Levaggi R; Department of Economics and Management, University of Brescia, Brescia, Italy.
Pertile P; Department of Economics, University of Verona, Verona, Italy.; Pokaż więcej
Źródło :: Health economics [Health Econ] 2021 Sep; Vol. 30 (9), pp. 2284-2286. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Costs*
Economics, Pharmaceutical*
Costs and Cost Analysis ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Does price deregulation increase drug price in China? An interrupted time series analysis.
Autorzy :: Xiong Y; School of Public Administration, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.; Center of Health Policy and Governance, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.
Xu J; School of Public Administration, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.; Center of Health Policy and Governance, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.
Gao Y; School of Public Health, Nantong University, Nantong, Jiangsu, China.; Pokaż więcej
Źródło :: The International journal of health planning and management [Int J Health Plann Manage] 2021 Sep; Vol. 36 (5), pp. 1653-1665. Date of Electronic Publication: 2021 May 24.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Costs*
Pharmaceutical Preparations*
China ; Costs and Cost Analysis ; Interrupted Time Series Analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Measuring Costs in Health Care: It Is Time to Think (and Count) Differently.
Autorzy :: Hawkins CM; Pokaż więcej
Źródło :: Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2021 Aug; Vol. 18 (8), pp. 1106-1107. Date of Electronic Publication: 2021 May 10.
Typ publikacji :: Journal Article
MeSH Terms :: Delivery of Health Care*
Health Care Costs*
Costs and Cost Analysis ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Costs for Statutorily Insured Dental Services in Older Germans 2012-2017.
Autorzy :: Krasowski A; Department of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin Berlin, Aßmannshauser Str. 4-6, 14197 Berlin, Germany.; Department of Restorative, Preventive and Pediatric Dentistry, zmk Bern, University of Bern, 3012 Bern, Switzerland.
Krois J; Department of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin Berlin, Aßmannshauser Str. 4-6, 14197 Berlin, Germany.
Paris S; Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin, 10117 Berlin, Germany.
Kuhlmey A; Institute of Medical Sociology and Rehabilitation Science, Charité-Universitätsmedizin, 10117 Berlin, Germany.
Meyer-Lueckel H; Department of Restorative, Preventive and Pediatric Dentistry, zmk Bern, University of Bern, 3012 Bern, Switzerland.
Schwendicke F; Department of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin Berlin, Aßmannshauser Str. 4-6, 14197 Berlin, Germany.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jun 21; Vol. 18 (12). Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dental Care*
Health Care Costs*
Aged ; Aged, 80 and over ; Berlin ; Costs and Cost Analysis ; Germany ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.
Autorzy :: Feldman WB; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Rome BN; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Brown BL; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Pokaż więcej
Źródło :: JAMA internal medicine [JAMA Intern Med] 2022 Jan 01; Vol. 182 (1), pp. 83-86.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Costs/*trends
Pharmacy Service, Hospital/*economics
Prescription Drugs/*economics
Prescription Fees/*statistics & numerical data
Hospital Costs ; Humans ; Insurance, Pharmaceutical Services ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Autorzy :: Lau D; Department of Medicine University of Alberta Edmonton AB Canada.
Sandhu RK; Mazankowski Alberta Heart InstituteUniversity of Alberta Edmonton AB Canada.; Canadian VIGOUR Centre University of Alberta Edmonton AB Canada.
Andrade JG; Division of Cardiology University of British Columbia Vancouver BC Canada.
Ezekowitz J; Mazankowski Alberta Heart InstituteUniversity of Alberta Edmonton AB Canada.; Canadian VIGOUR Centre University of Alberta Edmonton AB Canada.
So H; Department of Medicine University of Alberta Edmonton AB Canada.
Klarenbach S; Department of Medicine University of Alberta Edmonton AB Canada.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2021 Jul 20; Vol. 10 (14), pp. e019599. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Health Care Costs*
Anti-Arrhythmia Agents/*economics
Anti-Arrhythmia Agents/*therapeutic use
Atrial Fibrillation/*therapy
Catheter Ablation/*economics
Heart Failure/*physiopathology
Adult ; Aged ; Aged, 80 and over ; Alberta ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/economics ; Atrial Fibrillation/physiopathology ; Catheter Ablation/adverse effects ; Cost-Benefit Analysis ; Drug Costs ; Female ; Heart Failure/diagnosis ; Humans ; Male ; Markov Chains ; Middle Aged ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma.
Autorzy :: McBride A; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA.
MacDonald K; Matrix45, Tucson, AZ, USA.
Abraham I; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; Matrix45, Tucson, AZ, USA. Electronic address: .; Pokaż więcej
Źródło :: Leukemia research [Leuk Res] 2021 Jul; Vol. 106, pp. 106591. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Costs*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma, Non-Hodgkin/*drug therapy
Lymphoma, Non-Hodgkin/*epidemiology
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biosimilar Pharmaceuticals/administration & dosage ; Cost-Benefit Analysis ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Filgrastim/administration & dosage ; Health Care Costs ; Humans ; Polyethylene Glycols/administration & dosage ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Rituximab/adverse effects ; Rituximab/therapeutic use ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/therapeutic use
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Costs"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język